
China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. (CJJD) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
CJJD · free cash flow · updated Jun 15, 2026
Core FCF metrics
CJJD · FCF · TTM · margin & CAGRFree cash flow was −$4.1M for FY2024 (fiscal year ending 2024-03-31), down 13.5% year-over-year The FCF margin was -2.6%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
CJJD · P/FCF · FCF yield · FCF per shareChina Jo-Jo Drugstores, Inc. (CJJD) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.
FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.
Cash flow statement summary
CJJD · cash flow statement · operating / investing / financingFor FY2024, China Jo-Jo Drugstores, Inc. generated −$3.2M in operating cash flow and spent 1M in capital expenditures, yielding −$4.1M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
China Jo-Jo Drugstores, Inc. (CJJD) reported free cash flow of −$4.1M for FY2024 (fiscal year ending 2024-03-31), down 13.5% year-over-year. The FCF margin was -2.6%.
Based on available data, China Jo-Jo Drugstores, Inc. has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $15.1M in FY2012.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
CJJD free cash flow · 8 questionsChina Jo-Jo Drugstores, Inc. free cash flow was −$4.1M for FY2024, down 13.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$7.6M.
▸ Source: FMP /cash-flow-statement · US GAAP · China Jo-Jo Drugstores, Inc. · China Jo-Jo Drugstores, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026